Proteome Sciences Plc (PRM.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | -530 | 158 | 25 | -70 | 46 |
| Accounts receivable | -25 | 569 | 704 | -920 | 163 |
| Other Working Capital | 984 | 828 | 454 | -209 | -328 |
| Other Operating Activity | -475 | -2,381 | -1,664 | 3,339 | 912 |
| Operating Cash Flow | $-46 | $-826 | $-481 | $2,140 | $793 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -97 | -224 | -237 | -319 | -204 |
| Other Investing Activity | 0 | 0 | -187 | 0 | 0 |
| Investing Cash Flow | $-97 | $-224 | $-424 | $-319 | $-204 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 650 | 750 | N/A | N/A | N/A |
| Debt Repayment | N/A | 0 | -824 | N/A | N/A |
| Other Financing Activity | -854 | -599 | -238 | -209 | -400 |
| Financing Cash Flow | $-204 | $151 | $-1,062 | $-209 | $-400 |
| Exchange Rate Effect | N/A | 0 | 0 | -5 | -12 |
| Beginning Cash Position | 1,128 | 2,027 | 3,994 | 2,387 | 2,210 |
| End Cash Position | 781 | 1,128 | 2,027 | 3,994 | 2,387 |
| Net Cash Flow | $-347 | $-899 | $-1,967 | $1,612 | $189 |
| Free Cash Flow | |||||
| Operating Cash Flow | -46 | -826 | -481 | 2,140 | 793 |
| Capital Expenditure | -97 | -224 | -237 | -319 | -204 |
| Free Cash Flow | -143 | -1,050 | -718 | 1,821 | 589 |